Abstracts
16 June 2009
Vol. 2 No. 15 (2006)
https://doi.org/10.4081/hmr.v2i15.609

Secondary myelodysplastic syndrome/acute myeloid leukemia after autologous transplantation

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
359
Views
372
Downloads

Authors

Luca Laurenti
support@pagepress.org
Michela Tarnani
Patrizia Chiusolo
Giuseppe La Torre
Livio Pagano
Gina Zini
Mariagrazia Garzia
Marcella Zollino
Federica Sorà
Giuseppe Leone
Simona Sica
High-dose chemotherapy followed by autologous bone marrow (BM) or peripheral blood (PB) stem cell transplantation (SCT) are being used with increasing frequency in the treatment of hematopoietic malignancies and solid neoplasms. The improvement in survival after hematopoietic stem cell transplantation has drawn increased attention to late complications in long-term survivors.

Altmetrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

How to Cite



Secondary myelodysplastic syndrome/acute myeloid leukemia after autologous transplantation. (2009). Hematology Meeting Reports, 2(15). https://doi.org/10.4081/hmr.v2i15.609